NVST
NYSE
US
Envista Holdings Corporation Common Stock
$27,73
▲ +$0,79
(+2,93%)
Vol 54K
Kap. Pasar
$4.4B
P/E
93,9
ROE
1,5%
Margin
1,7%
Beta
0,98
52W
$15–$30
Konsensus Wall Street
20 analis · Apr 20267
Beli Kuat
5
Beli
8
Tahan
0
Jual
0
Jual Kuat
60,0%
Peringkat Beli
Grafik Harga
Saham Serupa
MASI
Masimo Corp
$7.0B
BAX
Baxter International Inc
$9.3B
GKOS
Glaukos Corp
$7.1B
TFX
Teleflex Inc
$5.7B
IRTC
iRhythm Holdings, Inc
$5.7B
TMDX
Transmedics Group Inc
P/E 45,3
$4.2B
ITGR
Integer Holdings Corp
P/E 29,6
$3.0B
LMAT
LeMaitre Vascular Inc
P/E 34,5
$1.8B
AORT
Artivion Inc
P/E 183,1
$1.8B
ABT
Abbott Laboratories
P/E 26,3
$165.2B
Pendapatan
Tingkat beat: 100,0%| Kuartal | EPS Estimasi | EPS Aktual | Kejutan |
|---|---|---|---|
| Des 2025 | $0,33 | $0,38 | +$0,05 |
| Sep 2025 | $0,28 | $0,32 | +$0,04 |
| Jun 2025 | $0,24 | $0,26 | +$0,02 |
| Mar 2025 | $0,21 | $0,24 | +$0,03 |
Pendapatan & Laba Kuartalan
| Kuartal | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Pendapatan | — | $652.9M | $616.9M | $682.1M | $669.9M | $750.6M |
| Laba Bersih | — | $1.2M | $18.0M | $26.4M | -$30.3M | $32.9M |
Tren Fundamental
| Metrik | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 1.5% | 1.5% |
| P/E (TTM) | 92.01 | 93.93 |
| Net Margin | 1.7% | 1.7% |
| Gross Margin | 55.0% | 55.0% |
| D/E Ratio | — | — |
| Current Ratio | 2.38 | 2.38 |
Rasio Utama
ROA (TTM)
0,8%
P/S (TTM)
1,62
P/B
1,1
EPS (TTM)
$0,28
CF/Share
$1,87
Pertumbuhan Pendapatan 3T
+1,9%
52W High
$30,42
52W Low
$14,72
$14,72
Rentang 52 Minggu
$30,42
Kesehatan Keuangan
Arus Kas Bebas
$91.7M
Utang Bersih
$386.0M
Kas
$1.2B
Total Utang
$1.6B
Per tanggal Des 31, 2025
Як NVST виглядає на тлі конкурентів у Health Care?
Група порівняння: Peers · Health Care (Peers) · 10 компаній
Оцінка NVST vs аналоги Health Care
P/E
92,0
▲
167%
di atas
rekan
(34,5)
vs Rekan
vs Industri
Lebih mahal
P/S
1,6
▼
60%
di bawah
rekan
(4,0)
vs Rekan
vs Industri
Undervalued
P/B
1,2
▼
78%
di bawah
rekan
(5,2)
vs Rekan
vs Industri
Undervalued
Дивідендна дохідність
—
▼
0%
di bawah
rekan
(1,1%)
vs Rekan
vs Industri
Sejajar
Прибутковість NVST vs аналоги Health Care
ROE
1,5%
▲
125%
di atas
rekan
(-6,1%)
vs Rekan
vs Industri
Di bawah rata-rata
Net margin
1,7%
▲
162%
di atas
rekan
(-2,8%)
vs Rekan
vs Industri
Di bawah rata-rata
Валова маржа
55,0%
▼
1%
di bawah
rekan
(55,9%)
vs Rekan
vs Industri
Sejajar
ROA
0,8%
▲
145%
di atas
rekan
(-1,9%)
vs Rekan
vs Industri
Di bawah rata-rata
Фінансове здоровʼя NVST vs аналоги Health Care
D/E ratio
—
▼
0%
di bawah
rekan
(106,5)
vs Rekan
vs Industri
Sejajar
Поточна ліквідність
2,4
▼
23%
di bawah
rekan
(3,1)
vs Rekan
vs Industri
Likuiditas rendah
Beta
1,0
▲
24%
di atas
rekan
(0,8)
vs Rekan
vs Industri
Lebih volatil
Радар фундаменталів NVST
NVST
Median rekan
Industri
NVST прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
NVST vs аналоги: ключові метрики
Aktivitas Orang Dalam
BearishPembelian
8
Penjualan
1
$290250
HAMMES ERIC D.
Chief Financial Officer · Feb 25
award
16055 shs
KEEL PAUL A
Chief Executive Officer · Feb 25
award
48670 shs
NANCE MARK E
General Counsel · Feb 25
award
12675 shs
REIS MISCHA
Officer · Feb 25
award
5915 shs
KAABI FAEZ C
Officer · Feb 25
award
13520 shs
BEFIDI ROBERT JR.
Officer · Feb 25
award
7605 shs
ACURIO VERONICA
Officer · Feb 25
award
7605 shs
NILSSON STEFAN
Officer · Feb 25
award
7605 shs
REIS MISCHA
Officer · Feb 10
sale
9675 shs
REIS MISCHA
Officer · Feb 10
conversion of exercise of derivative security
9675 shs
Terakhir 90 hari
Pemegang Terbesar
Top 5: 39,3%Blackrock Inc.
10,76%
$462.9M
Vanguard Group Inc
9,88%
$424.8M
Ariel Investments, LLC
7,34%
$315.9M
Dimensional Fund Advisors LP
5,91%
$254.1M
Morgan Stanley
5,41%
$232.5M
Per tanggal Des 31, 2025
Berita Terbaru
Belum ada berita terkait